[Clinical studies on the therapeutical usefulness of fluocinolone acetonide T-butylacetate-- a new topically active corticosteroid].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to M Miklaszewska.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The activity of granulocyte pyruvate kinase and glucose-6-phospho dehydrogenase in 12 patients with severe atopic dermatitis in active stage of disease and in remission was investigated. It was found that in active stage the activity of both enzymes was not significantly different than in healthy individuals. In remission pyruvate kinase activity was significantly decreased and glucose-6-phospho dehydrogenase activity was found to be non significantly decreased.
The phagocytic activity was determined in 18 patients with atopic dermatitis who were treated in the Dermatology Department, Medical Academy in Wrocław. Reduced phagocytic activity was found in 12 patients. In 3 cases this was caused by a defect in phagocytic cells, in the remaining 9 cases this was due to disturbances of the opsonizing properties of the serum. The serum of these patients caused mainly a fall of the bactericidal activity of the leucocytes, and this was caused more frequently by a deficit of the opsonizing factors than by the presence of inhibitor. In the sera attenuating the engulfing and intracellular killing of bacteria presence of immune complexes was demonstrated. The disappearance of immune complexes during treatment restored normal function of the serum during the process of phagocytosis.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.